A clinical study examining determined that systemical mediastinal lymph node dissection (LND) should no longer be recommended in stage T1 ground-glass (GGO)-dominant invasive lung adenocarcinoma..1
The phase 3 study, ECTOP-1009 (NCT04527419),2…
A clinical study examining determined that systemical mediastinal lymph node dissection (LND) should no longer be recommended in stage T1 ground-glass (GGO)-dominant invasive lung adenocarcinoma..1
The phase 3 study, ECTOP-1009 (NCT04527419),2…